ID
15427
Description
Alemtuzumab in Autoimmune Inflammatory Neurodegeneration: Mechanisms of Action and Neuroprotective Potential (ALAIN01) https://clinicaltrials.gov/ct2/show/NCT02419378 Principal Investigator Prof. Dr. Dr. Sven Meuth, University Hospital Muenster, Germany Part: Screening
Link
https://clinicaltrials.gov/ct2/show/NCT02419378
Keywords
Versions (5)
- 8/12/15 8/12/15 - Martin Dugas
- 8/12/15 8/12/15 - Martin Dugas
- 5/28/16 5/28/16 -
- 5/31/16 5/31/16 -
- 5/31/16 5/31/16 -
Uploaded on
May 31, 2016
DOI
To request one please log in.
License
Creative Commons BY 4.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Screening: Medical History Multiple Sclerosis ALAIN01 NCT02419378
Screening: Medical History Multiple Sclerosis ALAIN01 NCT02419378
Description
Medical history List
Description
Medical History: Description
Data type
text
Alias
- UMLS CUI [1]
- C0262926
Description
Medical History: Start Date
Data type
date
Alias
- UMLS CUI [1]
- C2826738
Description
Medical History: End Date
Data type
date
Alias
- UMLS CUI [1]
- C2826747
Description
Medical History: ongoing
Data type
text
Alias
- UMLS CUI [1]
- C2826680